Stress-induced cardiomyopathy associated with ipratropium bromide therapy in a patient with chronic obstructive pulmonary disease | Zendy

Filipa Melão | Zendy; José Pedro L. Nunes | Zendy; Mariana Vasconcelos | Zendy; Paula Dias | Zendy; Pedro Bernardo Almeida | Zendy; Rui Rodrigues | Zendy; Teresa Pinho | Zendy; António J. Madureira | Zendy; Maria Júlia Maciel | Zendy

Open Access

Stress-induced cardiomyopathy associated with ipratropium bromide therapy in a patient with chronic obstructive pulmonary disease

Author(s) -

Filipa Melão,

José Pedro L. Nunes,

Mariana Vasconcelos,

Paula Dias,

Pedro Bernardo Almeida,

Rui Rodrigues,

Teresa Pinho,

António J. Madureira,

Maria Júlia Maciel

Publication year - 2014

Publication title -

revista portuguesa de cardiologia

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.266

H-Index - 26

eISSN - 2174-2030

pISSN - 0870-2551

DOI - 10.1016/j.repc.2013.10.012

Subject(s) - ipratropium bromide , medicine , cardiology , cardiomyopathy , exacerbation , coronary artery disease , copd , ventricle , context (archaeology) , heart failure , pulmonary artery , asthma , bronchodilator , paleontology , biology

Stress-induced cardiomyopathy, also known as 'broken heart syndrome' or Takotsubo cardiomyopathy, is characterized by transient systolic dysfunction of the apical and/or mid segments of the left ventricle, in the absence of significant coronary artery disease. We report the case of a 56-year-old male patient with chronic obstructive pulmonary disease (COPD), with stress-induced cardiomyopathy associated with the use of ipratropium bromide, administered in the context of an acute exacerbation of COPD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research